(Q71119997)
Statements
RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes (English)
Hensold JO
Barth D
scientific article published on 01 July 1996